Candriam S.C.A. Zoetis Inc. Transaction History

Candriam S.C.A.

$16.8 Billion
Q2 2025

A detailed history of Candriam S.C.A. transactions in Zoetis Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 594,840 shares of ZTS stock, worth $87.1 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

594,840

Previous 498,761 19.26%

Holding current value

$87.1 Million

Previous $82.1 Million 12.96%

% of portfolio

0.55%

Previous 0.53%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$144.41 - $170.3 $13.9 Million - $16.4 Million	96,079 Added 19.26%	594,840 $92.8 Million
Q1 2025 May 14, 2025	BUY	$156.48 - $175.67 $61,809 - $69,389	395 Added 0.08%	498,761 $82.1 Million
Q4 2024 Feb 06, 2025	SELL	$162.24 - $194.42 $9.08 Million - $10.9 Million	-55,974 Reduced 10.1%	498,366 $81.2 Million
Q3 2024 Nov 13, 2024	BUY	$172.58 - $196.48 $31.6 Million - $36 Million	183,100 Added 49.32%	554,340 $108 Million
Q2 2024 Aug 05, 2024	BUY	$145.54 - $178.83 $8.72 Million - $10.7 Million	59,943 Added 19.26%	371,240 $64.4 Million
Q1 2024 May 03, 2024	BUY	$165.67 - $199.94 $16.6 Million - $20 Million	100,125 Added 47.41%	311,297 $52.7 Million
Q4 2023 Feb 14, 2024	BUY	$151.44 - $200.09 $25.2 Million - $33.4 Million	166,731 Added 375.17%	211,172 $41.7 Million
Q3 2023 Nov 13, 2023	BUY	$167.14 - $192.77 $246,698 - $284,528	1,476 Added 3.44%	44,441 $7.73 Million
Q2 2023 Aug 08, 2023	SELL	$160.94 - $186.23 $4.56 Million - $5.28 Million	-28,337 Reduced 39.74%	42,965 $7.4 Million
Q1 2023 May 12, 2023	SELL	$145.48 - $175.02 $3.15 Million - $3.78 Million	-21,624 Reduced 23.27%	71,302 $11.9 Million
Q4 2022 Feb 13, 2023	BUY	$131.14 - $157.47 $1.22 Million - $1.47 Million	9,315 Added 11.14%	92,926 $13.6 Million
Q3 2022 Nov 10, 2022	BUY	$148.29 - $182.55 $6.87 Million - $8.46 Million	46,319 Added 124.21%	83,611 $12.4 Million
Q2 2022 Aug 03, 2022	SELL	$155.97 - $200.09 $2.23 Million - $2.86 Million	-14,289 Reduced 27.7%	37,292 $6.41 Million
Q1 2022 May 13, 2022	BUY	$181.39 - $234.03 $347,180 - $447,933	1,914 Added 3.85%	51,581 $9.73 Million
Q4 2021 Feb 10, 2022	SELL	$193.69 - $247.03 $680,432 - $867,816	-3,513 Reduced 6.61%	49,667 $12.1 Million
Q3 2021 Nov 09, 2021	SELL	$189.29 - $209.69 $120,388 - $133,362	-636 Reduced 1.18%	53,180 $10.3 Million
Q2 2021 Jul 20, 2021	BUY	$155.9 - $187.99 $2.87 Million - $3.47 Million	18,437 Added 52.11%	53,816 $10 Million
Q4 2020 Jan 22, 2021	BUY	$157.07 - $174.35 $814,722 - $904,353	5,187 Added 17.18%	35,379 $5.86 Million
Q3 2020 Oct 19, 2020	SELL	$137.1 - $165.37 $281,466 - $339,504	-2,053 Reduced 6.37%	30,192 $4.99 Million
Q2 2020 Jul 23, 2020	SELL	$111.92 - $142.53 $1.13 Million - $1.44 Million	-10,137 Reduced 23.92%	32,245 $4.42 Million
Q4 2019 Jan 21, 2020	BUY	$116.25 - $133.25 $78,120 - $89,544	672 Added 1.61%	42,382 $6,000
Q3 2019 Oct 21, 2019	BUY	$112.57 - $128.43 $93,883 - $107,110	834 Added 2.04%	41,710 $5,000
Q2 2019 Aug 01, 2019	SELL	$97.98 - $114.28 $130,999 - $152,792	-1,337 Reduced 3.17%	40,876 $4.62 Million
Q1 2019 May 02, 2019	SELL	$81.56 - $100.67 $605,256 - $747,072	-7,421 Reduced 14.95%	42,213 $4.25 Million
Q4 2018 Feb 14, 2019	BUY	$79.28 - $95.27 $154,358 - $185,490	1,947 Added 4.08%	49,634 $4.25 Million
Q3 2018 Nov 07, 2018	SELL	$83.5 - $93.23 $88,176 - $98,450	-1,056 Reduced 2.17%	47,687 $4.37 Million
Q2 2018 Aug 14, 2018	SELL	$79.9 - $89.2 $165,313 - $184,554	-2,069 Reduced 4.07%	48,743 $4.15 Million
Q1 2018 May 09, 2018	SELL	$71.51 - $84.69 $33,824 - $40,058	-473 Reduced 0.92%	50,812 $4.24 Million
Q4 2017 Feb 07, 2018	BUY	$63.24 - $72.8 $7,715 - $8,881	122 Added 0.24%	51,285 $3.7 Million
Q3 2017 Nov 03, 2017	BUY	$59.73 - $65.4 $3.06 Million - $3.35 Million	51,163	51,163 $3.26 Million

Others Institutions Holding ZTS

# of Institutions

2,130

Shares Held

430M

Call Options Held

1.47M

Put Options Held

1.45M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $68.5B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account